与布罗XL相关的新发性病:一个罕见的病例
Ovais Rashid1,2,3, Priyanka Hooda1, Simranjeet Kaur1
1Centre of Excellence in Mental Health, Psychiatry, Atal Bihari Vajpayee Institute of Medical Sciences (ABVIMS) and Dr. RML Hospital, New Delhi, IND.
Cureus
|February 23, 2026
概括
布普罗皮昂XL是一种诺亚上腺素-多巴胺再吸收抑制剂 (NDRI),很少会导致新发作的. 这份病例报告详细介绍了一名患者,在开始服用布洛普后,他出现了运动和声部动,在停止治疗后得到了缓解.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学 是一个学科.
背景情况:
- 滴滴是突然的,快速的,非节律的运动或发声.
- 布普罗XL (一种北上腺素-多巴胺再吸收抑制剂) 已被批准用于抑郁症和戒烟.
- 提克是布洛的罕见副作用,与兴奋剂或SSRI不同.
研究的目的:
- 报告一种罕见的与布罗普 XL. 相关的新发性滴答病例.
- 要强调临床警对布洛普诱导的的重要性.
主要方法:
- 一个27岁的男性患者的病例报告.
- 患者开始接受布洛普里XL治疗抑郁症状.
- 观察到运动和声乐技能的发展.
主要成果:
- 患者出现了拍手 (运动) 和哨声/笑声 (声音) .
- 在停止服用布洛普里昂XL后,完全消失.
- 低剂量利开始用于控制.
结论:
- 布普罗XL很少会诱导新的发作.
- 临床医生应该警这种不良影响.
- 停止使用布洛普和使用像RISPERIDONE这样的药物治疗可以解决.
关键词:
药物不良反应 药物不良反应布洛普里昂 (Bupropion) 是一种可以抑郁 抑郁症 抑郁症 抑郁症 抑郁症上腺素-多巴胺再吸收抑制剂 (ndri)一个小小的小小的小小的小小的小小的小小的小小的小小的小小的小小的更多相关视频
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
1.0K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.0K
Bipolar Disorder
1.1K
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
1.1K
Mania and Antimanic Drugs: Overview
702
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
702
Bulimia Nervosa
852
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
852
Oral Drug Delivery Systems: Continuous-Release Systems
58
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
58
Binge Eating Disorders
560
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
560


